ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 118 filers reported holding ATEA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31,332 | -19.8% | 10,444 | -0.0% | 0.00% | – |
| Q2 2023 | $39,079 | +11.6% | 10,449 | -0.0% | 0.00% | – |
| Q1 2023 | $35,021 | -30.4% | 10,454 | -0.0% | 0.00% | – |
| Q4 2022 | $50,303 | -51.2% | 10,458 | -27.6% | 0.00% | – |
| Q2 2022 | $103,000 | -60.1% | 14,439 | -50.0% | 0.00% | -100.0% |
| Q4 2021 | $258,000 | -91.1% | 28,869 | -65.1% | 0.00% | -90.0% |
| Q3 2021 | $2,903,000 | +431.7% | 82,813 | +225.8% | 0.01% | +400.0% |
| Q2 2021 | $546,000 | -1.6% | 25,418 | +183.1% | 0.00% | 0.0% |
| Q1 2021 | $555,000 | +148.9% | 8,980 | +68.5% | 0.00% | +100.0% |
| Q4 2020 | $223,000 | – | 5,330 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $17,648,000 | 2.07% |
| EcoR1 Capital, LLC | 6,340,639 | $45,019,000 | 1.55% |
| CM Management, LLC | 200,000 | $1,420,000 | 1.51% |
| K2 PRINCIPAL FUND, L.P. | 1,606,059 | $11,403,000 | 1.26% |
| Cormorant Asset Management, LP | 1,547,181 | $10,985,000 | 0.83% |
| Privium Fund Management (UK) Ltd | 61,284 | $435,000 | 0.49% |
| Atom Investors LP | 30,911 | $219,000 | 0.10% |
| FEDERATED HERMES, INC. | 3,588,131 | $25,476,000 | 0.07% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 347,612 | $2,468,000 | 0.06% |
| BALYASNY ASSET MANAGEMENT L.P. | 1,799,507 | $12,777,000 | 0.04% |